2023 Part B Administrative Reverse Site Visit 2023
Resource updated 05/29/2024
Resource updated 05/29/2024
Resource updated 05/29/2024
Resource updated 05/29/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/29/2024
Resource updated 05/29/2024
Resource from the RWHAP Best Practices Compilation updated on 05/24/2024
Resource updated 05/29/2024
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
Tools developed by a Part A program to monitor programs and services.
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 04/12/2024
Resource updated 04/23/2024
Resource updated 05/01/2024
Recruitment and retention strategies that planning groups can use to support membership.
Resource updated 09/19/2023
Sample document presents the steps in the Planning Council member nomination process.
Resource updated 09/19/2023
Steps for conducting a town hall meeting as part of a community needs assessment/planning process.
Resource updated 09/19/2023
Workbooks for RWHAP planning bodies and other entities to self-assess their effectiveness.
Resource updated 09/19/2023
An orientation to Ryan White Planning Councils for prospective new members. Una introducción a los consejos de planificación para miembros recientes.
Resource updated 01/11/2024
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023